Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damian A Laber

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|August 7, 2021
Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single InstitutionConstantine N Logothetis, Ankita Patel, Jennifer Eatrides, et al.
Cancer Biology & Therapy|June 22, 2007
A phase I study of thalidomide, capecitabine and temozolomide in advanced cancerDamian A Laber, M Iltaf Khan, Goetz H Kloecker, et al.
Journal of Clinical Medicine|May 13, 2026
Management of Recurrent Venous Thromboembolism on AnticoagulationJennifer Eatrides, Avani Singh, Ankita Patel, et al.
American Journal of Clinical Oncology|May 20, 2009
Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessaryMichael V Jaglal, Damian A Laber, Forest W Arnold, et al.
Journal for Immunotherapy of Cancer|June 24, 2017
Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathyJose D Sandoval-Sus, Francis Mogollon-Duffo, Ankita Patel, et al.
American Journal of Clinical Oncology|August 8, 2006
A phase II study of higher dose docetaxel in androgen-independent prostate cancerDamian A Laber, Shawn D Glisson, Jeffery B Hargis, et al.
Journal of Cutaneous Pathology|June 10, 2008
IL-4 production by CD8+ lymphomatoid papulosis, type C, attracts background eosinophilsStephen P Slone, Alvin W Martin, Samuel R Wellhausen, et al.
Cancers|June 28, 2023
Insights into the Impact of Hesitancy on Cancer Care and COVID-19Nathan Visweshwar, Juan Felipe Rico, Irmel Ayala, et al.
Journal of Clinical Medicine|August 29, 2024
Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia VeraNathan Visweshwar, Bradley Fletcher, Michael Jaglal, et al.
European Journal of Haematology|November 20, 2023
Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective studyDamian A Laber, Parth C Patel, Constantine N Logothetis, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|August 7, 2021
Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single InstitutionConstantine N Logothetis, Ankita Patel, Jennifer Eatrides, et al.
Cancer Biology & Therapy|June 22, 2007
A phase I study of thalidomide, capecitabine and temozolomide in advanced cancerDamian A Laber, M Iltaf Khan, Goetz H Kloecker, et al.
Journal of Clinical Medicine|May 13, 2026
Management of Recurrent Venous Thromboembolism on AnticoagulationJennifer Eatrides, Avani Singh, Ankita Patel, et al.
American Journal of Clinical Oncology|May 20, 2009
Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessaryMichael V Jaglal, Damian A Laber, Forest W Arnold, et al.
Journal for Immunotherapy of Cancer|June 24, 2017
Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathyJose D Sandoval-Sus, Francis Mogollon-Duffo, Ankita Patel, et al.
American Journal of Clinical Oncology|August 8, 2006
A phase II study of higher dose docetaxel in androgen-independent prostate cancerDamian A Laber, Shawn D Glisson, Jeffery B Hargis, et al.
Journal of Cutaneous Pathology|June 10, 2008
IL-4 production by CD8+ lymphomatoid papulosis, type C, attracts background eosinophilsStephen P Slone, Alvin W Martin, Samuel R Wellhausen, et al.
Cancers|June 28, 2023
Insights into the Impact of Hesitancy on Cancer Care and COVID-19Nathan Visweshwar, Juan Felipe Rico, Irmel Ayala, et al.
Journal of Clinical Medicine|August 29, 2024
Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia VeraNathan Visweshwar, Bradley Fletcher, Michael Jaglal, et al.
European Journal of Haematology|November 20, 2023
Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective studyDamian A Laber, Parth C Patel, Constantine N Logothetis, et al.
Pageof 5